| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AXOGEN INC | 2,120,000 | 11,363,000 | 7.09% | ||
| 2 | ARIAD PHARMACEUTICALS INC | 1,250,000 | 7,988,000 | 4.98% | ||
| 3 | ULTRAGENYX PHARMACEUTICAL INC COM | 110,000 | 6,964,000 | 4.34% | ||
| 4 | FIBROGEN INC COM | 325,000 | 6,919,000 | 4.31% | ||
| 5 | PROTALIX BIOTHERAPEUTICS INC | 8,200,000 | 6,892,000 | 4.30% | ||
| 6 | MEDGENICS INC | 1,557,700 | 6,854,000 | 4.27% | ||
| 7 | ADAMAS PHARMACEUTICALS INC | 320,000 | 6,064,000 | 3.78% | ||
| 8 | CARA THERAPEUTICS INC | 855,000 | 5,318,000 | 3.32% | ||
| 9 | SAGE THERAPEUTICS | 165,000 | 5,290,000 | 3.30% | ||
| 10 | AMAG PHARMACEUTICALS INC COM | 220,000 | 5,148,000 | 3.21% | ||
| 11 | IMPRIMIS PHARMACEUTICALS INC | 1,250,000 | 4,963,000 | 3.09% | ||
| 12 | INOTEK PHARMACEUTICALS CORP | 645,000 | 4,773,000 | 2.98% | ||
| 13 | DEPOMED INC | 325,000 | 4,527,000 | 2.82% | ||
| 14 | AGIOS PHARMACEUTICALS INC | 105,000 | 4,263,000 | 2.66% | ||
| 15 | EAGLE PHARMACEUTICALS INC | 1,440,000 | 4,118,000 | 2.57% | ||
| 16 | BLUEPRINT MEDICINES CORP COM | 220,000 | 3,971,000 | 2.48% | ||
| 17 | GERON CORP | 1,325,000 | 3,869,000 | 2.41% | ||
| 18 | Foamix Pharmaceuticals Ltd. | 590,000 | 3,847,000 | 2.40% | ||
| 19 | CODEXIS INC | 1,178,500 | 3,665,000 | 2.29% | ||
| 20 | TG THERAPEUTICS INC COM | 415,000 | 3,536,000 | 2.21% | ||
| 21 | CHIMERIX INC | 675,000 | 3,449,000 | 2.15% | ||
| 22 | OPHTHOTECH CORP COM | 80,000 | 3,382,000 | 2.11% | ||
| 23 | IMMUNOMEDICS INC | 1,325,000 | 3,313,000 | 2.07% | ||
| 24 | XENON PHARMACEUTICALS INC | 400,000 | 2,796,000 | 1.74% | ||
| 25 | AMARIN CORP PLC | 1,760,000 | 2,693,000 | 1.68% | ||
| 26 | Intec Pharma Ltd | 638,000 | 2,629,000 | 1.64% | ||
| 27 | Nabriva Therapeutics AG | 273,800 | 2,453,000 | 1.53% | ||
| 28 | EAGLE PHARMACEUTICALS INC COM | 60,000 | 2,430,000 | 1.52% | ||
| 29 | AFFIMED N V | 610,000 | 2,281,000 | 1.42% | ||
| 30 | ZOGENIX INC | 240,000 | 2,218,000 | 1.38% | ||
| 31 | RETROPHIN INC COM | 150,000 | 2,049,000 | 1.28% | ||
| 32 | SUPERNUS PHARMACEUTICALS INC COM | 125,000 | 1,906,000 | 1.19% | ||
| 33 | TRILLIUM THERAPEUTICS INC | 195,000 | 1,804,000 | 1.12% | ||
| 34 | EDGE THERAPEUTICS INC | 185,000 | 1,693,000 | 1.06% | ||
| 35 | CYNAPSUS THERAPEUTICS INC | 121,000 | 1,440,000 | 0.90% | ||
| 36 | ADAPTIMMUNE THERAPEUTICS PLC | 175,300 | 1,425,000 | 0.89% | ||
| 37 | CORIUM INTERNATIONAL INC | 360,000 | 1,390,000 | 0.87% | ||
| 38 | AURIS MED HLDG AG | 340,000 | 1,238,000 | 0.77% | ||
| 39 | OHR PHARMACEUTICAL INC | 366,000 | 1,175,000 | 0.73% | ||
| 40 | PROTEON THERAPEUTICS INC | 150,000 | 1,161,000 | 0.72% | ||
| 41 | XOMA CORP DEL | 1,350,000 | 1,044,000 | 0.65% | ||
| 42 | TENAX THERAPEUTICS INC COM | 499,600 | 1,024,000 | 0.64% | ||
| 43 | ACHAOGEN INC COM | 255,000 | 704,000 | 0.44% | ||
| 44 | NEKTAR THERAPEUTICS COM | 50,000 | 688,000 | 0.43% | ||
| 45 | MEDIVATION INC | 14,500 | 667,000 | 0.42% | ||
| 46 | Evoke Pharma Inc | 130,000 | 662,000 | 0.41% | ||
| 47 | PROTHENA CORP PLC | 14,000 | 576,000 | 0.36% | ||
| 48 | NEURODERM LTD | 38,500 | 544,000 | 0.34% | ||
| 49 | Nivalis Therapeutics Inc | 100,000 | 417,000 | 0.26% | ||
| 50 | ACLARIS THERAPEUTICS INC COM | 18,000 | 341,000 | 0.21% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001546927-16-000499, filed 2016.05.27).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
